ClinicalTrials.gg
Enrolling by invitationNCT06654427OBTICUpdated May 11, 2026

Trauma-Informed Obstetric Care: Development and Implementation of a Toolkit for Obstetrics (OBTIC)

An interventional study of Obstetric Trauma Informed Care Toolkit in Trauma, Obstetrics Trauma and Pregnancy Related, sponsored by The Miriam Hospital. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by The Miriam Hospital · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
165
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Many pregnant women have experienced trauma, which can make perinatal care stressful and increase the risk of pregnancy-related health conditions. However, obstetric providers can modify procedures to reduce distress and enhance patients' sense of control and safety. Although obstetric providers frequently care for trauma survivors, most are not trained in trauma-informed care (TIC). Additionally, there are no data on feasibility, appropriateness, or acceptability of TIC tools and interventions in the context of obstetrics. The goal of this project is to develop the first, stakeholder-informed obstetric TIC toolkit composed of treatment protocols, clinician training, trauma and violence screening tools, and other resources to help obstetric providers apply TIC practices to all clinical interactions in addition to identifying and providing support for trauma survivors. The obstetric TIC intervention toolkit (OB-TIC) will be developed in collaboration with key stakeholders (pregnant and postpartum patients, nurses, physicians, and administrators) to ensure that it is feasible, acceptable, appropriate, cost-effective, and clinically useful. Current practices and preferences will be characterized in qualitative interviews with stakeholders which will inform the development of OBTIC in collaboration with a community working group of stakeholders. A pilot implementation trial of OB-TIC will be conducted in outpatient obstetrics clinics to gather real-world data that will inform the final intervention toolkit, which will be tested on a larger scale in future studies.

Read the detailed description

The goal of this study is to develop a stakeholder-informed toolkit for obstetric providers and patients to support the implementation of trauma-informed care (TIC) in routine clinical practice. Following interviews with providers and pregnant/postpartum participants as well as convening with a community working group of stakeholders, an OBTIC toolkit blueprint will be drafted for testing.

In the pilot implementation phase, all clinicians and administrators at an outpatient obstetrics clinic will participate in the OBTIC intervention. However, only providers who consent to participate in surveys and interviews will be contacted by the PI to complete surveys (assessment of attitudes related to TIC and usefulness of toolkit components) at the mid-point (month 2) and after completion of the pilot (month 4). Clinicians will also be interviewed as a group (physicians and nurses separately) following a staff meeting; interviews will assess perceived acceptability, feasibility, appropriateness and helpfulness of the toolkit. Additionally, 12-20 postpartum participants, who were treated at the clinic during the pilot, will be recruited for brief semi-structured qualitative interviews and surveys following the completion of the pilot. In order to assess adoption of the trauma screening component of the TIC toolkit, I will conduct chart review of initial prenatal visits at baseline (3 months prior) during (9 months of the pilot trial) and after completion (3 months following completion) of the pilot trial to assess rates of screening. To assess exploratory efficacy outcomes, I will use chart review to collect data on 1) Perinatal care: care engagement (appointment adherence, attendance of postpartum follow-up), and care choices (elective augmentation of delivery); 2) Maternal-infant outcomes: breastfeeding (initiation and continuation), infant birthweight, and post-partum pain; 3) Perinatal mental health: depression (EPDS or PHQ-9), and anxiety (GAD-7). In the sample of patients who elect to participate in interviews, I will also assess prior trauma exposure (ACE and BTQ), PTSD symptoms (PCL-5 and City Birth Trauma Scale) and experiences of discrimination and safety in care (Personal Discrimination Multi-Item Measure).

Sample sizes for the qualitative components of the study were determined in order to achieve adequate distribution to stratify by key study variables (trauma exposure, pregnancy status, provider type). For the pilot implementation trial, the aim of the quantitative aims is to generate data needed to evaluate the feasibility and acceptability of the designed intervention, and to generate estimates of key parameters (variance of outcome measures) to approach power and sample size estimation for an efficacy study.

02

Conditions studied

  • Trauma
  • Obstetrics Trauma
  • Pregnancy Related

Browse trials for

Keywords

  • trauma informed care
  • Obstetrics
03

In context

Wounds and Injuries

2,217 studies on the registry are indexed under Wounds and Injuries; 441 are open to participants now.

This study's planned enrollment of 165 is above the median of 70 across 1,424 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

The Miriam Hospital is the lead sponsor of 182 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria for pregnant and postpartum patients for individual interviews:

  • ≥ 18 years old
  • under the care of an obstetrician or nurse practitioner in the U.S.,
  • English-speaking
  • have had ≥2 prenatal care encounters, and postpartum if they delivered a surviving infant within the past 12 months
  • received care at either of the pilot sites during the pilot trial.
  • Pregnant and postpartum participants will be eligible for the trauma-exposed group if they

    • report a history of trauma in childhood or adulthood,
    • are ≥1 year from the time of the traumatic experience
    • are not currently at-risk for harm from self or others
    • are willing to discuss experiences related to trauma and are able to do so without experiencing undue distress.
  • Patient participants will be eligible for the non-trauma group if they deny trauma.

Inclusion criteria

Inclusion criteria for provider participants:

  • Practicing physicians or nurses
  • ≥ 6 months of experience in obstetrics
  • English speaking
  • Clinician Participants (providers in the participating clinics) will be enrolled in the pilot trial of the obstetric trauma-informed care toolkit intervention.
  • Clinician participants will be enrolled for group or individual interviews if they consent to do so and meet above criteria.

Exclusion criteria

Exclusion Criteria:

Patient participants will be excluded from the study interviews if they report

  • a current unsafe environment (determined by the Assessment of Immediate Safety)
  • report suicidal ideation (as determined by the PHQ9)
  • report difficulty discussing experiences related to trauma.

Provider participants will be excluded from the study if they do not work at one of the pilot clinics. Provider participants will be excluded from the study interviews if they do not consent to be interviewed.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
165 participants (estimated)

Study arms

  • Experimental
    Implementation of OBTIC

    The OB-TIC intervention toolkit will be pilot tested in outpatient obstetrics clinics. OB-TIC will be implemented for 9 months during which time I will assess providers' and patients' perceptions of acceptability, appropriateness, and feasibility of OB-TIC. Adoption of OB-TIC, attitudes towards TIC, appointment adherence and care choices, maternal-infant health outcomes, and patient mental health will be assessed before, during, and after the pilot.

    Behavioral: Obstetric Trauma Informed Care Toolkit

Interventions

  • BehavioralObstetric Trauma Informed Care Toolkit

    The OB-TIC toolkit will include provider and staff training on trauma- informed care and information on trauma-related perinatal concerns; trauma assessment tools; trauma-informed procedure modifications; clinical language guides; patient-facing resources including birth strategies, referral resources, and education; and clinical language. The OB-TIC intervention will utilize the toolkit to integrate trauma-informed care into clinical practice. Implementation strategies will be assessed to determine the most effective method for integrating OB-TIC content into practice.

    Also known as: OBTIC, STAR-OB

06

What researchers measure

Primary outcomes

  1. Evaluation of intervention components for adaptation and scale-up implementation

    Once the OB-TIC toolkit is complete, I will work with my mentorship team to create a survey to assess the most frequently used components of the toolkit. For example, if OB-TIC includes trauma-informed birth strategies, mental health referrals, and a modified exam procedure checklist, the survey would list each of these components and ask clinicians how often each component was used, rate how useful the component was, and whether they made changes to any of the materials.

    Time frame: Surveys to evaluate specific components of the OB-TIC toolkit will be given in early implementation (2-3 months)

  2. Evaluation of intervention components for adaptation and scale-up implementation

    Once the OB-TIC toolkit is complete, I will work with my mentorship team to create a survey to assess the most frequently used components of the toolkit. For example, if OB-TIC includes trauma-informed birth strategies, mental health referrals, and a modified exam procedure checklist, the survey would list each of these components and ask clinicians how often each component was used, rate how useful the component was, and whether they made changes to any of the materials.

    Time frame: Surveys to evaluate specific components of the OB-TIC toolkit will be given in sustainment (6-12 months)

  3. Change in Acceptability of Intervention Measure

    Clinicians will rate acceptability on a 5-point ordinal scale ranging from "completely disagree" to "completely agree". The measure consists of 4 items and has a test-retest reliability Cronbach alpha of .83.

    Time frame: Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)

  4. Change in Intervention Appropriateness Measure

    Clinicians will rate appropriateness on a 5-point ordinal scale ranging from "completely disagree" to "completely agree". The measure consists of 4 items and has a test-retest reliability Cronbach alpha of .87.

    Time frame: Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)

  5. Change in Feasibility of Intervention Measure

    Clinicians will rate feasibility on a 5-point ordinal scale ranging from "completely disagree" to "completely agree". The measure consists of 4 items and has a test-retest reliability Cronbach alpha of .88.

    Time frame: Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)

Secondary outcomes

  1. Change in Patient health questionnaire (PHQ-9)

    The PHQ-9 is a standardized measure of depression which has been used widely in obstetric settings. It consists of 9 questions and is scored from 0 to 3. Clinical significance is determined by a score of 5 or higher for mild depression and 10 or higher for moderate depression. The PHQ9 has an internal consistency of .89.

    Time frame: The PHQ9 will be used to assess patient mood changes before (3 months prior) during (9 months) and 3 months after the pilot trial via chart review

  2. City Birth Trauma Scale

    The City Birth Trauma Scale is a 29 item scale that assesses perinatal experiences according to DSM 5 PTSD criteria. It has been shown to have reliability of .92.

    Time frame: 9-12 months post-intervention

  3. Change in Appointment Adherence

    Appointment Adherence will be measured by assessing the ratio of attended to scheduled appointments. The type of appointment will also be recorded (ultrasound, initial obstetric visit, pelvic exam, medication consultation, glucose testing, etc)

    Time frame: Chart review will be used to assess the change in ratio of attended to scheduled appointments before (3 months prior) during (for 9 months of implementation) and after (3 months following the 9 month implementation period) the pilot trial.

  4. Change in Elective augmentation of delivery

    Patient preferences for augmentation of delivery will be recorded via chart review and dichotomized as yes or no.

    Time frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review

  5. Change Breastfeeding frequency

    Initiation and length of continuation of breastfeeding up to 6 weeks as noted at postpartum follow-up appointment.

    Time frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review

  6. Change in average infant birth-weight

    Infant birthweight as recorded in delivery note in medical record.

    Time frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review

  7. Change in Post-partum pain ratings

    Postpartum pain as recorded in postpartum note in medical record.

    Time frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review

  8. Change in Generalized Anxiety Disorder Assessment (GAD-7)

    The GAD-7 is a self-report measure of anxiety and worry with higher scores indicating greater severity in symptoms. The GAD-7 has demonstrated excellent internal consistency and reliability (.92).

    Time frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review

  9. Posttraumatic stress disorder checklist for DSM-5 (PCL-5)

    The PCL-5 is a 20 item self-report measure assessing 20 post-traumatic stress disorder symptoms according to criteria in the Diagnostic and Statistical Manual (DSM-5). It has demonstrated good internal consistency and reliability (.94). A total severity score is calculated from the sum of the responses to the 20 items.

    Time frame: After completion of the pilot trial (9-12 months after the start of implementation), a subset of patients will be recruited for interviews and completion of surveys

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Since the bulk of data collected for this project are qualitative data, the decision has been made not to share these data as they may be identifying of participants.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jun 2027, 23 months after the start.

Of 546 non-industry interventional studies with no phase under Wounds and Injuries, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 49. This study's planned 23 months is close to that.

Counting every sponsor, half of 599 studies reached it within 24 months; a quarter within 9 and three quarters within 48.

Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2023
First posted
Oct 23, 2024
StartActual
Jul 1, 2025
Primary completionEst.
Jun 1, 2027
CompletionEst.
Jun 30, 2027
Last update
May 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06654427
Collaborators
Women and Infants Hospital of Rhode Island
Responsible party
Sponsor
First posted
Oct 23, 2024
Start date
Jul 1, 2025
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
May 11, 2026

Study contacts

Laura G Ward, Ph.D.
principal investigator · The Miriam Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion